Sign In
Buy NBY
NBY Dividends Insights
NBY pays dividends . Last paid amount was $0.80 at Sep 30, 2025. As of today, dividend yield (TTM) is 272.13%.
Dividend Score Premium
AI Analysis of NBY
Built on AI-powered analysis of yield strength, recent news, payout trends, and 10-year dividend growth consistency.
Dividend Yield Range
AI Analysis of NBY
| Dividend Analysis |
|
Key Stats
| Dividend Yield (TTM) | 272.13% |
|---|---|
| Frequency | |
| 1Y Growth | 0% |
| Payout Ratio | 0 |
| Amount Per Share | $0.80 |
|
NovaBay Pharmaceuticals, Inc has not yet announced its next dividend date. Last payment date was: Sep 30, 2025.
|
|
NBY Dividend Payout History
To ensure a understanding of NBY's dividend performance, consider examining the historical payout ratios and how they align with the company's earnings. Fluctuations in payout amounts may reflect changes in the company's dividend policy or earnings stability.
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Sep 30, 2025 | Sep 30, 2025 | Sep 30, 2025 | $0.80 | 48.48% |
Dividend Sustainability
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. Overall, a more vigilant stance is recommended given the company's tentative dividend profile.
DSS - Sustainability score
DSGP - Growth potential
NBY Dividend Calculator
Dividend Calculator is designed to forecast the potential returns from NBY dividends based on your individual investment size or the number of shares you own. Simply enter your total investment amount to see the cumulative dividend payment you could receive over a specified period.
Read how to invest in NBY stock here.
Comparing NBY to Sector and Country
NBY pays a solid dividend yield of 272.13%, which is higher than the average of the bottom 25% of dividend payers in the US market (0.567%). NBY’s dividend yield is higher than the average of the top 25% of dividend payers in the Healthcare sector in the US market (8.84%).
